Icariside E4
Icariside E4, a natural compound from Ulmus minor, exhibits hypolipidemic effects by activating AMPK and inhibiting MID1IP1 in HepG1 cells. Its mechanism involves downregulating SREBP-1c and FASN, supporting its research potential for fatty liver disease, with demonstrated antioxidant and anti-inflammatory activities in vitro.
Product Specifications
CAS Number
126253-42-7
Field of Research
Epigenetics & Chromatin, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Smiles
C (O) [C@@H]1C=2C (O[C@H]1C3=CC (OC) =C (O[C@H]4[C@H] (O) [C@H] (O) [C@@H] (O) [C@H] (C) O4) C=C3) =C (OC) C=C (CCCO) C2
Molecular Formula
C26H34O10
Molecular Weight
506.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
302500-ML490 100 µL
IGSF21 (Immunoglobulin Superfamily Member 21, IgSF21, IGSF21) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
MBS7102785-01 0.05 mg (Yeast)
Recombinant Streptomyces coelicolor Putative membrane protein SCO0839 (SCO0839), partial
Sign In for Pricing
View Details MBS7102785-02 0.2 mg (Yeast)
Recombinant Streptomyces coelicolor Putative membrane protein SCO0839 (SCO0839), partial
Sign In for Pricing
View Details MBS7102785-03 0.5 mg (Yeast)
Recombinant Streptomyces coelicolor Putative membrane protein SCO0839 (SCO0839), partial
Sign In for Pricing
View Details MBS7102785-04 1 mg (Yeast)
Recombinant Streptomyces coelicolor Putative membrane protein SCO0839 (SCO0839), partial
Sign In for Pricing
View Details